Daniel R. Freidman Sells 15,000 Shares of Caleres, Inc. (NYSE:CAL) Stock

Caleres, Inc. (NYSE:CAL) insider Daniel R. Freidman sold 15,000 shares of the stock in a transaction that occurred on Monday, April 8th. The shares were sold at an average price of $37.00, for a total value of $555,000.00. Following the completion of the sale, the insider now directly owns 64,167 shares of the company’s stock, valued at $2,374,179. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Caleres Price Performance

Shares of CAL stock opened at $36.16 on Friday. The stock has a market cap of $1.27 billion, a P/E ratio of 7.52 and a beta of 1.99. Caleres, Inc. has a one year low of $16.85 and a one year high of $41.94. The stock has a fifty day moving average price of $37.51 and a 200 day moving average price of $31.80.

Caleres (NYSE:CAL) last issued its earnings results on Tuesday, March 19th. The textile maker reported $0.86 EPS for the quarter, hitting the consensus estimate of $0.86. The firm had revenue of $697.10 million during the quarter, compared to analysts’ expectations of $694.32 million. Caleres had a return on equity of 29.77% and a net margin of 6.10%. Caleres’s quarterly revenue was up .1% compared to the same quarter last year. During the same period last year, the business earned $0.65 earnings per share. Equities research analysts anticipate that Caleres, Inc. will post 4.43 EPS for the current year.

Caleres Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 12th. Shareholders of record on Thursday, March 28th will be issued a dividend of $0.07 per share. The ex-dividend date is Wednesday, March 27th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.77%. Caleres’s payout ratio is presently 5.82%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on CAL. KeyCorp began coverage on Caleres in a research report on Wednesday, February 7th. They issued a “sector weight” rating for the company. Loop Capital increased their price objective on Caleres from $40.00 to $45.00 and gave the company a “buy” rating in a research report on Wednesday, March 20th. Finally, Piper Sandler raised their target price on Caleres from $30.00 to $35.00 and gave the stock a “neutral” rating in a research report on Wednesday, March 20th. Two equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $40.00.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in CAL. State of Wyoming bought a new position in shares of Caleres during the second quarter valued at $29,000. Acadian Asset Management LLC bought a new position in shares of Caleres during the first quarter valued at $32,000. Captrust Financial Advisors lifted its holdings in shares of Caleres by 30.4% during the first quarter. Captrust Financial Advisors now owns 5,467 shares of the textile maker’s stock valued at $106,000 after acquiring an additional 1,275 shares during the period. SG Americas Securities LLC bought a new position in shares of Caleres during the third quarter valued at $131,000. Finally, Point72 Middle East FZE bought a new position in shares of Caleres during the fourth quarter valued at $143,000. 98.44% of the stock is owned by institutional investors.

About Caleres

Caleres, Inc engages in the retail and wholesale of footwear business in the United States, Canada, East Asia, and internationally. It operates through Famous Footwear and Brand Portfolio segments. The company offers licensed, branded, and private-label athletic, casual, and dress footwear products. The company provides brand name athletic, casual, and dress shoes, including Nike, Skechers, adidas, Vans, Crocs, Converse, Puma, Birkenstock, New Balance, Under Armour, Dr.